Decoding the Expression Pattern of MUC3A in Gastric Adenocarcinoma: Unveiling the Key to Successful Immunotherapy

Immunohistochemistry was used to determine the percentage of MUC3A-positive tumor cells in primary and metastatic tumor sites of 190 gastric adenocarcinoma patients.